Stockreport

Turn Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Updates

Turn Therapeutics Inc.  (TTRX) 
PDF Successfully began trading on NASDAQ under ticker TTRX on October 8, 2025 Strengthened its Board of Directors with the appointments of Arthur Golden and Dr. Kent Kester [Read more]